Skip to content
10-K

Annual Report

KRAIG BIOCRAFT LABORATORIES, INC. KBLB

0001493152-26-013630

← back to feed
Filed
Mar 30, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 30, 2026 1.1B sh
Shares Diluted FY 2025 · Dec 31, 2025 1.06B sh
Shares Diluted FY 2025 · Dec 31, 2024 1.04B sh
Capex FY 2025 · Dec 31, 2025 $5.4K
Capex FY 2025 · Dec 31, 2024 $4.24K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$1.79M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$1.84M
Cash And Equivalents FY 2025 · Dec 31, 2025 $1.79M
Cash And Equivalents FY 2025 · Dec 31, 2024 $673.26K
Stockholders Equity FY 2025 · Dec 31, 2025 −$8M
Stockholders Equity FY 2025 · Dec 31, 2024 −$8.15M
Stockholders Equity FY 2025 · Dec 31, 2023 −$5.71M
Current Liabilities FY 2025 · Dec 31, 2025 $10.45M
Current Liabilities FY 2025 · Dec 31, 2024 $9.61M
Total Liabilities FY 2025 · Dec 31, 2025 $10.56M
Total Liabilities FY 2025 · Dec 31, 2024 $9.65M
Current Assets FY 2025 · Dec 31, 2025 $1.87M
Current Assets FY 2025 · Dec 31, 2024 $740.29K
Total Assets FY 2025 · Dec 31, 2025 $2.57M
Total Assets FY 2025 · Dec 31, 2024 $1.51M
Eps Diluted FY 2025 · Dec 31, 2025 $0.00
Eps Diluted FY 2025 · Dec 31, 2024 $0.00
Eps Basic FY 2025 · Dec 31, 2025 $0.00
Eps Basic FY 2025 · Dec 31, 2024 $0.00
Sga Expense FY 2025 · Dec 31, 2025 $1.96M
Sga Expense FY 2025 · Dec 31, 2024 $1.75M
Rd Expense FY 2025 · Dec 31, 2025 $165.76K
Rd Expense FY 2025 · Dec 31, 2024 $164.37K
Net Income FY 2025 · Dec 31, 2025 −$3.62M
Net Income FY 2025 · Dec 31, 2024 −$3.4M
Operating Income FY 2025 · Dec 31, 2025 −$3.37M
Operating Income FY 2025 · Dec 31, 2024 −$3.07M